NCT00695526View on ClinicalTrials.gov

Effects of Cranberry Extractive on the Lipid Profiles in Subjects With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions
Type 2 Diabetes
Interventions
DIETARY_SUPPLEMENT

cranberry

cranberry extractive in powder product (by Triarco Industries, Inc. NJ, USA) and encapsulated in dose of 500mg/capsule (by Topo digital tech co., Taiwan). By one capsule after each of three meals per day.

Trial Locations (1)

407

outpatient clinic of the Division of Endocrinology and Metabolism in Taichung Veterans General Hospital, Taichung

All Listed Sponsors
lead

Taichung Veterans General Hospital

OTHER

NCT00695526 - Effects of Cranberry Extractive on the Lipid Profiles in Subjects With Type 2 Diabetes | Biotech Hunter | Biotech Hunter